Vascular Access Devices
The U.S. vascular access device market is growing with rising hospitalization rates, expanding infusion therapy, and increasing demand for safer and longer-term intravenous access solutions. Our research provides actionable insights into market size, technology adoption, competitive developments, and investment opportunities across central venous catheters, PICCs, peripheral IV catheters, implantable ports, and related accessories.
The U.S. non-tunneled central venous catheters market is projected to expand from USD 1.76 billion in 2026 to USD 2.48 billion by 2032 at a 5.85% CAGR. Growth is propelled by over 5 million annual ICU admissions, surging acute sepsis resuscitations, and stringent CLABSI penalties accelerating hospital adoption of advanced antimicrobial, antithrombogenic multi-lumen platforms and real-time navigation guidance systems.
Read Report Details
The U.S. Tunneled Central Venous Catheters Market is projected to grow from USD 2.67 billion in 2026 to USD 4.14 billion by 2032 at a 7.58% CAGR. Growth is driven by the rising prevalence of end-stage renal disease, expanding oncology infusions, and procedural shifts toward ambulatory surgery centers. Dual-lumen polyurethane designs and antimicrobial-coated catheters dominate future market expansion.
Read Report Details
The U.S. extended dwell catheters market is expanding rapidly from USD 2.58 billion in 2026 to USD 5.52 billion by 2032 at a 13.66% CAGR. Driven by vessel health protocols, difficult venous access management, and hospital initiatives to curb CLABSI penalties, extended dwell and midline catheters provide a vital intermediate vascular access solution across acute and outpatient settings.
Read Report Details
The U.S. Midline Catheters Market is projected to expand from USD 1.58 billion in 2026 to USD 2.78 billion by 2032, registering a 9.88% CAGR. Driven by the clinical imperative to eliminate CLABSI penalties, resolve Difficult Venous Access (DIVA), and support outpatient parenteral therapy, health systems are rapidly standardizing on advanced power-injectable and antithrombogenic midline catheters across acute and post-acute care.
Read Report Details
The U.S. PICC lines market is expanding from USD 1.48 billion in 2026 to USD 2.38 billion by 2032 at an 8.25% CAGR. Growth is anchored by rising oncology regimens, expanding outpatient antimicrobial therapies, and nurse-led bedside placements using ECG tip-confirmation. Advanced antithrombogenic biomaterials and power-injectable systems continue to dominate clinical adoption across acute and home settings.
Read Report Details
The U.S. Peripherally Inserted Central Catheters Market is expanding rapidly, projected to grow from USD 1.70 billion in 2026 to USD 2.78 billion by 2032 at an 8.54% CAGR. Growth is anchored by rising oncology infusions, expanding outpatient parenteral antimicrobial therapy (OPAT), nurse-led vascular access teams, real-time ECG tip-confirmation navigation, and high-pressure power-injectable catheter technology across acute and home settings.
Read Report Details
The U.S. Central Venous Catheters Market is projected to expand from USD 2.08 billion in 2026 to USD 3.24 billion by 2032 at a 7.65% CAGR. Expansion is propelled by over five million annual catheter placements, rising oncologic infusions, end-stage renal disease care, and the rapid clinical adoption of bedside ultrasound guidance and antimicrobial-impregnated catheter ecosystems.
Read Report Details
The U.S. Long Peripheral Intravenous Catheters Market is rapidly expanding, driven by the rising prevalence of difficult intravenous access (DIVA) and the shift toward ultrasound-guided vascular preservation. Expected to grow at a 10.50% CAGR to reach $2.15 billion by 2032, this market benefits heavily from technological advancements like all-in-one Seldinger technique kits, reducing central line dependencies and catheter-related bloodstream infections.
Read Report Details
The U.S. Short Peripheral Intravenous Catheters Market is valued at USD 2.23 billion in 2026 and is projected to reach USD 3.42 billion by 2032, expanding at a 7.39% CAGR. Growth is fueled by over 330 million annual catheter placements, stringent OSHA sharps compliance, the clinical shift toward clinically indicated removal, and rapid health system adoption of integrated closed-system catheters.
Read Report Details
The U.S. Peripheral Intravenous Catheters Market is projected to expand from USD 2.75 billion in 2026 to USD 4.31 billion by 2032 at a 7.80% CAGR. Growth is anchored by over 300 million annual insertions, rigorous OSHA safety compliance, and accelerated clinical migration toward integrated closed systems, advanced polyurethanes, and extended-dwell catheters designed to minimize complications and optimize hospital workflow.
Read Report Details